Special Report

Published in:
Volume 6 / Year 2017 / Issue 3

Physician associations comment on FDA’s interchangeability guidance

Page: 120-1

Abstract: Comments from physician associations on the US Food and Drug Administration’s draft guidance on interchangeability of biosimilars are presented in this paper. Various issues were discussed; this paper highlights… Read More »

Go Back Print